Stock info Haemonetics Corp | Filter  Basic-Info

Haemonetics Corp

Haemonetics Corp mainly operates in the health care eq. & services sector. The global health care companies gained around 102 percent over the last 10 years. As from 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

Past year was a negative year for Haemonetics Corp investors

Over the past year the company' stock gained around 33 percent. Over the period 2011-2016 the stock rose a massive 40,87 percent. Haemonetics Corp's revenues between 2011 and 2015 were very volatile and moved between 727,84 million dollars and 910,37 million dollars. The net results between 2011 and 2015 were far from constant and fluctuated between 79,98 million dollars and 16,9 million dollars.

The American company didn't pay out any dividends (in the past 5 years).

Haemonetics Corp' balance mostly financed with equity

At the end of 2015 the health care company's balance sheet equaled 1,49 billion dollars. 659,3 million dollars (44,38 percent of the total balance sheet) was financed by debt. The American company's price/earnings-ratio was 38. So the market valued the stock at 38 times the 2015' earnings per share. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

At the end of 2015 the market capitalization (the number of shares outstanding multiplied by the stock price) of the health care company equaled around 1,6 billion dollars. At the end of 2015 the American company had around 51,53 million stocks listed.

All Haemonetics Corp's annual reports can be found here. More information about Haemonetics Corp can be found it's website. .